Home

ADME (Absorption, Distribution, Metabolism, and Excretion): Lead Characterization and Optimization

October 29, 2019

Introducing our newest CPRIT-funded GCC Center for Pharmacokinetics/Pharmacodynamics and Formulation (CCPF).  Sponsored by CPRIT, CCPF, and the GCC Innovative Drug Discovery and Development Consortium, this conference will include a “How-to” session on approaching PK (ADME)/PD and formulation studies.  Topics discussed will include protein:protein interactions, biologics, small molecules and examples of projects from users of the core.  Additional sessions will include experts who will cover IND-enabling studies and regulatory considerations, and industry professionals who will present on current state-of-the-art and how those boundaries are being pushed as we move into the future of drug development.

Confirmed Speakers:

Leslie Benet
Professor
Bioengineering and Therapeutic Sciences
University of California San Francisco

S. W. Johnny Lau
Clinical Pharmacologist

Fadi Ibrahim
Senior Principal Scientist
Pfizer

Oscar Ekpenyong
Senior Scientist
Merck

Jeff Larson
VP
Product Development
Iterion

Stan Watowich
Professor
Biochemistry & Molecular Biology
UT Medical Branch at Galveston

Robert Tsai
Associate Professor
Center for Translational Cancer Research
Texas A&M Institute of Biosciences and Technology

Marc Cox
Professor
Biological Sciences
UT El Paso

Chun Li
Professor and Director
Cancer Systems Systems Imaging
MD Anderson Cancer Center

Cinzia Stella
Senior Scientist and Team Leader
Genentech

Diana Chow, University of Houston

Special thanks to CPRIT for their support of this Program.